Evidence map›Paper›PMID 35262643›Full record

ArticleThe Biochemical journal2022

Distinct phosphorylation signals drive acceptor versus free ubiquitin chain targeting by parkin.

Karen M Dunkerley, Anne C Rintala-Dempsey, Giulia Salzano, Roya Tadayon, Dania Hadi, Kathryn R Barber, Helen Walden, Gary S Shaw

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. MTFR1L is a cardiac antiaging factor for maintenance of mitochondrial homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Capturing the catalytic intermediates of parkin ubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Mitophagy in the aging nervous system.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Karen M DunkerleyDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
Anne C Rintala-DempseyDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
Giulia SalzanoInstitute of Molecular Cellular and Systems Biology, University of Glasgow, Glasgow G12 8QQ, U.K.
Roya TadayonDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
Dania HadiDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
Kathryn R BarberDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
Helen WaldenInstitute of Molecular Cellular and Systems Biology, University of Glasgow, Glasgow G12 8QQ, U.K.ORCID 0000-0002-4289-4810
Gary S ShawDepartment of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.ORCID 0000-0002-4685-9625
Western University · CAUniversity of Glasgow · GB

Funding

CIHR PJT 166019Wellcome Trust 209347/Z/17/Z
6 · The paper itself

Abstract

The RBR E3 ligase parkin is recruited to the outer mitochondrial membrane (OMM) during oxidative stress where it becomes activated and ubiquitinates numerous proteins. Parkin activation involves binding of a phosphorylated ubiquitin (pUb), followed by phosphorylation of the Ubl domain in parkin, both mediated by the OMM kinase, PINK1. How an OMM protein is selected for ubiquitination is unclear. Parkin targeted OMM proteins have little structural or sequence similarity, with the commonality between substrates being proximity to the OMM. Here, we used chimeric proteins, tagged with ubiquitin (Ub), to evaluate parkin ubiquitination of mitochondrial acceptor proteins pre-ligated to Ub. We find that pUb tethered to the mitochondrial target proteins, Miro1 or CISD1, is necessary for parkin recruitment and essential for target protein ubiquitination. Surprisingly, phosphorylation of parkin is not necessary for the ubiquitination of either Miro1 or CISD1. Thus, parkin lacking its Ubl domain efficiently ubiquitinates a substrate tethered to pUb. Instead, phosphorylated parkin appears to stimulate free Ub chain formation. We also demonstrate that parkin ubiquitination of pUb-tethered substrates occurs on the substrate, rather than the pUb modification. We propose divergent parkin mechanisms whereby parkin-mediated ubiquitination of acceptor proteins is driven by binding to pre-existing pUb on the OMM protein and subsequent parkin phosphorylation triggers free Ub chain formation. This finding accounts for the broad spectrum of OMM proteins ubiquitinated by parkin and has implications on target design for therapeutics.

Indexed as

UbiquitinUbiquitin-Protein LigasesMitochondrial ProteinsPhosphorylationUbiquitinationMitochondrial ProteinsUbiquitinUbiquitin-Protein Ligasesfluorescencephosphorylationprotein–protein interactionsprotein structureubiquitinubiquitin ligases

Identifiers

PMID35262643
PMCPMC9022993
OpenAlexW4220997556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.